NCI Community Oncology Research Program

NCI Community Oncology Research Program
Name	NCI Community Oncology Research Program
Established	2014
Country	United States
Parent	National Cancer Institute

Contents

NCI Community Oncology Research Program is a national clinical research network created to bring oncology clinical trials and cancer control studies to community settings across the United States. It connects local hospitals, academic centers, community physicians, and cancer centers to the National Cancer Institute clinical trials enterprise and the broader biomedical research infrastructure. The program aims to translate discoveries from institutions such as Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Mayo Clinic, and Johns Hopkins Hospital into care delivered at sites affiliated with networks like American Society of Clinical Oncology and cooperative groups including the Alliance for Clinical Trials in Oncology.

History

The program originated from initiatives by the National Cancer Institute and policy shifts influenced by reports from bodies such as the Institute of Medicine and the National Academies of Sciences, Engineering, and Medicine. Early precursors included networks led by Lance Armstrong Foundation-era survivorship advocacy and trials coordination efforts tied to Cancer and Leukemia Group B and Radiation Therapy Oncology Group. Formal reorganization in 2014 integrated components from the NCI Community Cancer Centers Program and the Community Clinical Oncology Program and aligned with strategic priorities set during administrations of Barack Obama and scientific leadership at National Institutes of Health. Legislative context involved stakeholders including members of the United States Congress and advisory councils like the National Cancer Advisory Board.

Governance incorporates a multi-tiered model linking local practice-based research networks, regional research bases, and national oversight from the National Cancer Institute. Participating entities include academic partners such as University of California, San Francisco, University of Pennsylvania Health System, University of Miami Health System, and regional hospitals like Cleveland Clinic and Kaiser Permanente. Oversight bodies and committees draw expertise from institutions such as Fred Hutchinson Cancer Center, City of Hope National Medical Center, and cooperative groups like Children's Oncology Group. The program operates with site principal investigators, protocol review committees influenced by standards from Food and Drug Administration guidance, and data management systems interoperable with platforms used by National Cancer Data Base contributors and partners including ClinicalTrials.gov.

The program conducts phase II and III therapeutic trials, cancer control studies, prevention trials, and translational research integrating biomarkers from laboratories at Broad Institute and Sanger Institute collaborations. Trials address cancers treated at community sites such as breast cancer clinics affiliated with Susan G. Komen Foundation initiatives, lung cancer programs working with American Lung Association, and gastrointestinal oncology services linked to centers like MD Anderson Cancer Center. Studies often use trial designs informed by methodologists from Johns Hopkins Bloomberg School of Public Health and statistical groups aligned with National Surgical Adjuvant Breast and Bowel Project. Protocol development involves partnerships with cooperative groups including the SWOG Cancer Research Network and data safety monitoring by boards including experts from Duke University School of Medicine. The network supports precision oncology pilots incorporating genomic testing pipelines originally developed at institutions like Broad Institute and Baylor College of Medicine.

Community engagement leverages collaborations with advocacy organizations such as American Cancer Society, LIVESTRONG Foundation, and patient groups formed around centers like Dana-Farber Cancer Institute and Memorial Sloan Kettering Cancer Center. Outreach programs coordinate with federally qualified health centers and local health departments such as those in Los Angeles County and Cook County, Illinois and with minority health initiatives advocated by National Institute on Minority Health and Health Disparities. Education and accrual efforts reference cancer survivorship resources from Institute of Medicine reports and tools adapted by academic partners including Columbia University Irving Medical Center and Yale School of Medicine. The network fosters diversity in enrollment through collaborations with Historically Black Colleges and Universities like Howard University and Hispanic-Serving Institutions such as University of Texas at El Paso.

Primary funding derives from appropriations administered by the National Cancer Institute within the National Institutes of Health budget, supplemented by grants and cooperative agreements with entities including private philanthropic foundations like Bill & Melinda Gates Foundation and industry sponsors such as Pfizer and Roche. Strategic research partnerships involve academic medical centers, cooperative groups like Alliance for Clinical Trials in Oncology and SWOG, and data-sharing collaboratives connected to initiatives such as the Cancer Moonshot launched during the Joe Biden administration. Contractual, regulatory, and intellectual property matters engage offices including the Office of Management and Budget and legal counsel versed in policies from the Department of Health and Human Services.

The network has increased trial access in rural and underserved regions served by institutions such as University of New Mexico Hospital and Maine Medical Center, improved accrual diversity reflecting initiatives promoted by National Cancer Advisory Board recommendations, and accelerated dissemination of protocols developed at centers like Fred Hutchinson Cancer Center and MD Anderson Cancer Center. Publications and presentations from network sites appear in journals such as Journal of Clinical Oncology, The Lancet Oncology, and New England Journal of Medicine, and influence guidelines from organizations like National Comprehensive Cancer Network and American Society of Clinical Oncology. Outcomes include measurable increases in community-site enrollment, uptake of guideline-concordant care at hospitals like Vanderbilt University Medical Center, and contributions to national data repositories used by researchers at Harvard Medical School and Stanford University School of Medicine.

Category:Cancer research networks